|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Operating expenses: | ||
| Research and development expenses, net | ||
| General and administrative expenses | ||
| Operating loss | ||
| Financial expense (income), net | ||
| Net loss and comprehensive loss | ||
| Basic net loss per share (in Dollars per share) | ||
| Diluted net loss per share (in Dollars per share) | ||
| Weighted average number of ordinary share used in computing basic net loss per share (in Shares) | ||
| Weighted average number of ordinary share used in computing diluted net loss per share (in Shares) |
Loading...
